1.Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2.Executive Summary 3.Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4.Key Insights 4.1 Fertility Statistics - Key Countries, 2017 4.2 New Product Launch 4.3 Key Industry Trends 4.4 Regulatory Scenario - Key Countries 4.5 Key Technological Advancements 4.6 Recent Industry Developments - Partnerships, Mergers & Acquisitions 5.Global Contraceptive Devices Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings/ Summary 5.2. Market Analysis, Insights and Forecast – By Product Type 5.2.1 Male Contraceptive Devices 5.2.2 Female Contraceptive Devices 5.2.2.1 Female Condoms, Diaphragms & Sponges 5.2.2.2 Vaginal Rings 5.2.2.3 Intrauterine Devices 5.2.2.4 Sub-dermal Implants 5.2.2.5 Others 5.3. Market Analysis, Insights and Forecast – By Technology 5.3.1 Hormonal Contraceptives 5.3.2 Barrier Contraceptives 5.4. Market Analysis, Insights and Forecast – By Distribution Channel 5.4.1 Hospital Pharmacy 5.4.2 Retail Pharmacy 5.4.3 Clinics 5.4.4 Online Channel 5.4.5 Public Channel & NGOs 5.4.6 Others 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1 North America 5.5.2 Europe 5.5.3 Asia Pacific 5.5.4 Latin America 5.5.5 Middle East & Africa 6.North America Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025 6.1. Key Findings/ Summary 6.2. Market Analysis, Insights and Forecast– By Product Type 6.2.1 Male Contraceptive Devices 6.2.2 Female Contraceptive Devices 6.2.2.1 Female Condoms, Diaphragms & Sponges 6.2.2.2 Vaginal Rings 6.2.2.3 Intrauterine Devices 6.2.2.4 Sub-dermal Implants 6.2.2.5 Others 6.3. Market Analysis, Insights and Forecast – By Technology 6.3.1 Hormonal Contraceptives 6.3.2 Barrier Contraceptives 6.4. Market Analysis, Insights and Forecast – By Distribution Channel 6.4.1 Hospital Pharmacy 6.4.2 Retail Pharmacy 6.4.3 Clinics 6.4.4 Online Channel 6.4.5 Public Channel & NGOs 6.4.6 Others 6.5. Market Analysis, Insights and Forecast – By Country 6.5.1 U.S. 6.5.2 Canada 7.Europe Contraceptive Devices Market Analysis, Insights and Forecast 2014-2025 7.1. Key Findings/ Summary 7.2. Market Analysis, Insights and Forecast – By Product Type 7.2.1 Male Contraceptive Devices 7.2.2 Female Contraceptive Devices 7.2.2.1 Female Condoms, Diaphragms & Sponges 7.2.2.2 Vaginal Rings 7.2.2.3 Intrauterine Devices 7.2.2.4 Sub-dermal Implants 7.2.2.5 Others 7.3. Market Analysis, Insights and Forecast – By Technology 7.3.1 Hormonal Contraceptives 7.3.2 Barrier Contraceptives 7.4. Market Analysis, Insights and Forecast – By Distribution Channel 7.4.1 Hospital Pharmacy 7.4.2 Retail Pharmacy 7.4.3 Clinics 7.4.4 Online Channel 7.4.5 Public Channel & NGOs 7.4.6 Others 7.5. Market Analysis, Insights and Forecast – By Countries/Sub regions 7.5.1 U.K. 7.5.2 Germany 7.5.3 France 7.5.4 Italy 7.5.5 Spain 7.5.6 Scandinavia 7.5.7 Rest of Europe 8.Asia Pacific Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025 8.1. Key Findings/ Summary 8.2. Market Analysis, Insights and Forecast – By Product Type 8.2.1 Male Contraceptive Devices 8.2.2 Female Contraceptive Devices 8.2.2.1 Female Condoms, Diaphragms & Sponges 8.2.2.2 Vaginal Rings 8.2.2.3 Intrauterine Devices 8.2.2.4 Sub-dermal Implants 8.2.2.5 Others 8.3. Market Analysis, Insights and Forecast – By Technology 8.3.1 Hormonal Contraceptives 8.3.2 Barrier Contraceptives 8.4. Market Analysis, Insights and Forecast – By Distribution Channel 8.4.1 Hospital Pharmacy 8.4.2 Retail Pharmacy 8.4.3 Clinics 8.4.4 Online Channel 8.4.5 Public Channel & NGOs 8.4.6 Others 8.5. Market Analysis, Insights and Forecast – By Countries/Sub regions 8.5.1 Japan 8.5.2 China 8.5.3 India 8.5.4 Southeast Asia 8.5.5 Australia 8.5.6 Rest of Asia Pacific 9.Latin America Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025 9.1. Key Findings/ Summary 9.2. Market Analysis, Insights and Forecast – By Product Type 9.2.1 Male Contraceptive Devices 9.2.2 Female Contraceptive Devices 9.2.2.1 Female Condoms, Diaphragms & Sponges 9.2.2.2 Vaginal Rings 9.2.2.3 Intrauterine Devices 9.2.2.4 Sub-dermal Implants 9.2.2.5 Others 9.3. Market Analysis, Insights and Forecast – By Technology 9.3.1 Hormonal Contraceptives 9.3.2 Barrier Contraceptives 9.4. Market Analysis, Insights and Forecast – By Distribution Channel 9.4.1 Hospital Pharmacy 9.4.2 Retail Pharmacy 9.4.3 Clinics 9.4.4 Online Channel 9.4.5 Public Channel & NGOs 9.4.6 Others 9.5. Market Analysis, Insights and Forecast – By Countries/Sub regions 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Rest of Latin America 10 Middle East & Africa Contraceptive Devices Market Analysis, Insights and Forecast, 2014-2025 10.1. Key Findings/ Summary 10.2. Market Analysis, Insights and Forecast – By Product Type 10.2.1 Male Contraceptive Devices 10.2.2 Female Contraceptive Devices 10.2.2.1 Female Condoms, Diaphragms & Sponges 10.2.2.2 Vaginal Rings 10.2.2.3 Intrauterine Devices 10.2.2.4 Sub-dermal Implants 10.2.2.5 Others 10.3. Market Analysis, Insights and Forecast – By Technology 10.3.1 Hormonal Contraceptives 10.3.2 Barrier Contraceptives 10.4. Market Analysis, Insights and Forecast – By Distribution Channel 10.4.1 Hospital Pharmacy 10.4.2 Retail Pharmacy 10.4.3 Clinics 10.4.4 Online Channel 10.4.5 Public Channel & NGOs 10.4.6 Others 10.5. Market Analysis, Insights and Forecast – By Countries/Sub regions 10.5.1 South Africa 10.5.2 GCC 10.5.3 Rest of Middle East & Africa 11.Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1 Bayer AG 11.5.2 Pfizer Inc. 11.5.3 Janssen Global Services, LLC 11.5.4 Teva Pharmaceutical Industries Ltd. 11.5.5 Merck & Co., Inc. 11.5.6 Mylan N.V. 11.5.7 Allergan 11.5.8 ReckittBenckiser Group plc 11.5.9 Veru Inc. 11.5.10 Church & Dwight Co., Inc. 11.5.11 Medisafe Distribution Inc. 11.5.12 Other Prominent Players 12.Strategic Recommendation

Bayer AG Pfizer Inc. Janssen Global Services, LLC Teva Pharmaceutical Industries Ltd. Merck & Co., Inc. Mylan N.V. Allergan Reckitt Benckiser Group plc Veru Inc. Church & Dwight Co., Inc. Medisafe Distribution Inc. Other players